List view / Grid view
18 July 2018 | By Verena Brucklacher-Waldert (Crescendo Biologics)
ATPliteTM and ATPlite 1step are robust, rapid, high-throughput luminescence assays used to assess a compound’s druggability.
17 July 2018 | By IDBS
In today’s modern world, data is everywhere. This eBook will guide you through the steps of how to achieve more with accurate data.
17 July 2018 | By Adam Carlson, Dawn Nida, Jeanine Hinterneder, Jen Carlstrom (PerkinElmer)
Quickly and easily quantitate immune checkpoint markers using a fraction of the sample volume required by traditional ELISAs...
17 July 2018 | By BMG Labtech GmbH
In this video, Becky Allsopp from Sygnature Discovery talks about Drug Discovery Research and how she uses the Microplate Reader PHERAstar FSX for their research.
16 July 2018 | By Drug Target Review
It may be better to examine the urine and the blood of patients suspected of tumours of the plasma cells...
16 July 2018 | By Catherine Lautenschlager (PerkinElmer), Hong Cao (PerkinElmer)
AlphaLISA® provides a robust assay that facilitates the design and development of antibody therapeutics.
16 July 2018 | By Drug Target Review
The expression of PI3Ky increases during infection by T.cruzi, providing an essential response controlling the parasite and avoiding inflammation...
13 July 2018 | By Drug Target Review
IGF-1 activated by p38 may be a therapeutic target
12 July 2018 | By Drug Target Review
New statistical method, ALFRED, could identify predisposition for cancers by using cancer genome data sets to identify risk variants.
11 July 2018 | By IDBS
This whitepaper explains how you can find ways to optimise the holistic preclinical development process...
22 June 2018 | By Drug Target Review
Addressing the optimisation of hits derived from a target-agnostic phenotypic screen, using a strategy based on combining bioactivity profiling and reference compound characterisation...
15 June 2018 | By IntelliCyt
The Intellicyt Mouse IgG Type and Titer Kit is a high throughput, multiplexed assay kit that enables analyses of isotype, titer and cell health in a single assay...
15 June 2018 | By IntelliCyt Corporation
Analyse isotype titer and cell health in one assay...
14 June 2018 | By Drug Target Review
The administration of silibinin in patients with brain metastasis reduces lesions without causing any adverse effects, according to a study led by researchers at the Spanish National Cancer Research Centre (CNIO).
13 June 2018 | By Drug Target Review
Scientists have deployed a novel genetic screen to search for synthetic viable interactions on special lines of Fanconi Anaemia-defective cells...
Send this to a friend
Follow: